Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
Portfolio Pulse from Benzinga Insights
The article highlights a surge in options activity for Bristol-Myers Squibb (NYSE:BMY), with a predominantly bearish sentiment among large investors. Over the past month, 75% of the trades were bearish, with significant volume and open interest in both puts and calls. Analysts have mixed ratings, with price targets ranging from $43 to $48.
May 21, 2024 | 3:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bristol-Myers Squibb has seen a significant increase in options activity, with 75% of trades being bearish. The stock is currently down 1.22% at $42.83, and analysts have set price targets between $43 and $48.
The majority of options trades (75%) are bearish, indicating a negative short-term outlook. The stock price has already declined by 1.22%, and analysts' price targets suggest limited upside potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100